SouthState’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
SouthState's BMRN Position: Q3 2026 in Review
SouthState held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 14 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #1174.
SouthState first reported a position in BMRN in Q1 2025 and has held it in 7 quarters since. The position peaked at $7.49K in Q1 2025. 434 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- SouthState held 14 shares of BioMarin Pharmaceuticals worth $840 as of Q3 2026.
- SouthState left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1174 holding.
- SouthState first reported a position in BioMarin Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- SouthState's BioMarin Pharmaceuticals position peaked at $7.49K in Q1 2025.
- 434 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.